Endonuclease G (EndoG) is a mitochondrial enzyme that becomes an apoptotic nuclease when released from the mitochondrial intermembrane space. EndoG will digest either DNA or RNA, but at physiological ionic strength, RNA is a much more favorable substrate as compared to chromatin. This indicates that EndoG’s major in vivo function(s) may be: (i) an apoptotic RNase, and/or (ii) an apoptotic DNase in the presence of additional co-activators. In the present study we have searched for factors that modulate the activity of human EndoG on DNA substrates. We demonstrate that EndoG forms complexes with AIF and FEN-1 but not with PCNA. Interestingly, heat shock proteins 70 interact with EndoG and are involved in the regulation of its activity. Purified Hsp70 prevented stimulation of EndoG DNase activity by other nuclear factors in the ATP-dependent manner.
Similar content being viewed by others
References
Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980; 68: 251–306.
Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88: 347–354.
Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365.
Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770–776.
Kaufman SH. Hengartner MO. Programmed cell death: Alive and well in the new millenium. Trends Cell Biol 2001; 11: 526–534.
Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990; 136: 593–608.
Zhang J, Xu M. Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol 2002; 12: 84–89.
Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175–184.
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50.
Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol 1998; 8: 537–540.
Liu X, Li P, Widlak P, et al. DFF40 induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci USA 1998; 95: 8461–8466.
Woo EJ, Kim YG, Kim MS, et al. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol Cell 2004; 14: 531–539.
Li LY, Xu L, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412: 95–99.
Cote J, Ruiz-Carillo A. Primers for mitochondrial DNA replication generated by Endonuclease G. Science 1993; 261: 765–769.
Huang KJ, Zemelman BV, Lehman IR. Endonuclease G, a candidate human enzyme for the initiation of genomic inversion in hepes simplex type 1 virus. J Biol Chem 2002; 277: 21071–21079.
Parrish JZ, Li L, Klotz K, Ledwich D, Wang X, Xue D. Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature 2001; 412: 90–94.
van Loo G, Schotte P, van Gurp M, et al. Endonuclease G: A mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 2001; 8: 1136–1142.
Zhang J, Dong M, Li L, et al. Endonuclease G is required for early embryogenesis and normal apoptosis in mice. Proc Natl Acad Sci USA 2003; 100: 15782–15787.
Schafer P, Scholz SR, Gimadutdinow O, et al. Structural and functional characterization of mitochondrial EndoG, a sugar non-specific nuclease which plays an important role during apoptosis. J Mol Biol 2004; 338: 217–228.
Widlak P, Li LY, Wang X, Garrard WT. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates; cooperation with exonuclease and DNaseI. J Biol Chem 2001; 276: 48404–48409.
Ikeda S, Ozaki K. Action of mitochondrial Endonuclease G on DNA damaged by L-ascorbic acid, peplomycin and cis-diamminedichloroplatinum (II). Biochem Biophys Res Commun 1997; 235: 291–294.
Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003; 22: 4385–4399.
Wang X, Yang C, Chai J, Shi Y, Xue D. Mechanism of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 2002; 298: 1587–1592.
Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441–446.
Ye H, Cande C, Stephanou NC, et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002; 9: 680–684.
Parrish JZ, Xue D. Functional genomic analysis of apoptotic DNA degradation in C. elegans. Mol Cell 2003; 11: 987–996.
Henneke G, Friedrich-Heineken E, Hubscher U. Flap endonuclease 1: A novel tumour suppresser protein. Trends Biochem Sci 2003; 28: 384–390.
Parrish JZ, Yang C, Shen B, Xue D. CRN-1, a Caenorhabditis elegans FEN-1 homologue, cooperates with CPS-6/EndoG to promote apoptotic DNA degradation. EMBO J 2003; 22: 3451–3460.
Penninger JM, Kroemer G. Mitochondria, AIF and caspases—rivaling for cell death execution. Nat Cell Biol 2003; 5: 97–99.
Menoret A. Purification of recombinant and endogenous HSP70s. Methods 2004; 32: 7–12.
Widlak P, Li P, Wang X, Garrard WT. Cleavage preferences of the apoptotic endonuclease DFF40 (Caspase-activated DNase or Nuclease) on naked DNA and chromatin substrates. J Biol Chem 2000; 275: 8226–8232.
Widlak P, Lanuszewska J, Cary RB, Garrard WT. Subunit structures and stoichiometries of human DFF proteins before and after induction of apoptosis. J Biol Chem 2003; 278: 26915–26922.
Widlak P, Garrard WT. Ionic and cofactor requirements for the activity of the apoptotic endonuclease DFF40/CAD. Mol Cell Biochem 2001; 218: 125–130.
Hughes FM, Cidlowski JA. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv Enzyme Reg 1999; 39: 157–171.
Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry 2003; 42: 1805–1812.
Warbrick E. PCNA binding through a conserved motif. BioEssays 1998; 20: 195–199.
Nollen EAA, Morimoto RI. Chaperoning signaling pathways: Molecular chaperones as stress-sensing ‘heat shock’ proteins. J Cell Sci 2002; 115: 2809–2816.
Sreedhar AS, Csermely P. Heat shock proteins in the regulation of apoptosis: New strategies in tumor therapy. A comprehensive review. Pharmacol Therapeutics 2004; 101: 227–257.
Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97: 7871–7876.
Seo JS, Park YM, Kim JI, et al. T cell lymphoma in transgenic mice expressing the human Hsp70 gene. Biochem Biophys Res Commun 1996; 218: 582–587.
Volloch VZ, Sherman MY. Oncogenic potential of Hsp72. Oncogene 1999; 17: 3648–3651.
Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000; 2: 476–483.
Beere HM, Wolf BB, Cain K, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000; 2: 469–475.
Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839–843.
Sakahira H, Nagata S. Co-translational foldind of caspase-activated DNase with Hsp70, Hsp40, and inhibitor of caspase-activated DNase. J Biol Chem 2002; 277: 3364–3370.
Liu Q-L, Kishi H, Ohtsuka K, Muraguchi A. Heat shock protein 70 binds caspase-activated DNase and enhances its activity in TCR-stimulated T cells. Blood 2003; 102: 1788–1796.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalinowska, M., Garncarz, W., Pietrowska, M. et al. Regulation of the human apoptotic DNase/RNase Endonuclease G: involvement of Hsp70 and ATP. Apoptosis 10, 821–830 (2005). https://doi.org/10.1007/s10495-005-0410-9
Issue Date:
DOI: https://doi.org/10.1007/s10495-005-0410-9